Skip to main content

Behcet's Disease News

Related terms: Behcets, Behcet's Syndrome

FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

SUMMIT, N.J.--(BUSINESS WIRE) July 19, 2019 – Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) 30 mg twice daily (BID) for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Otezla, adalimumab, etanercept